Project Details
Description
Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) with Intraperitoneal Interleukin- 2 in Women with Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/17 → 7/30/22 |
Funding
- FATE THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.